Crossover Post-herpetic Neuralgia (PHN)
Public ClinicalTrials.gov record NCT01305538. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-blind, Placebo-controlled, Cross-over Study of the Efficacy and Safety of BMS-954561 in Patients With Post-herpetic Neuralgia (PHN)
Study identification
- NCT ID
- NCT01305538
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Bristol-Myers Squibb
- Industry
- Enrollment
- 100 participants
Conditions and interventions
Conditions
Interventions
- BMS-954561 Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2011
- Primary completion
- Jan 31, 2012
- Completion
- May 31, 2012
- Last update posted
- Dec 6, 2015
2011 – 2012
United States locations
- U.S. sites
- 19
- U.S. states
- 14
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Research Center | Phoenix | Arizona | 85023 | — |
| Torrance Clinical Research | Lomita | California | 90717 | — |
| Alpine Clinical Research Center | Boulder | Colorado | 80304 | — |
| Brain Matters Research | Delray Beach | Florida | 33445 | — |
| Renstar Medical Research | Ocala | Florida | 34471 | — |
| Compass Research, Llc | Orlando | Florida | 32806 | — |
| Comprehensive Clinical Development, Inc. | St. Petersburg | Florida | 33716 | — |
| Drug Studies America | Marietta | Georgia | 30060 | — |
| Commonwealth Biomedical Research, Llc | Madisonville | Kentucky | 42431 | — |
| Analgesic Solutions | Natick | Massachusetts | 01760 | — |
| Quest Research Institute | Farmington Hills | Michigan | 48334 | — |
| The Center For Pharmaceutical Research. Pc | Kansas City | Missouri | 64114 | — |
| Medex Healthcare Research, Inc | St Louis | Missouri | 63117 | — |
| Finger Lakes Clinical Research | Rochester | New York | 14618 | — |
| Wake Research Associates, Llc | Raleigh | North Carolina | 27612 | — |
| Pmg Research Of Winston-Salem | Winston-Salem | North Carolina | 27103 | — |
| Radiant Research, Inc. | Akron | Ohio | 44311 | — |
| Cor Clinical Research | Oklahoma City | Oklahoma | 73103 | — |
| Futuresearch Trials Of Neurology | Austin | Texas | 78731 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01305538, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 6, 2015 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01305538 live on ClinicalTrials.gov.